Literature DB >> 21056904

Arterial thrombosis in ambulatory cancer patients treated with chemotherapy.

Marcello Di Nisio, Noemi Ferrante, Beatrice Feragalli, Michele De Tursi, Stefano Iacobelli, Franco Cuccurullo, Ettore Porreca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21056904     DOI： 10.1016/j.thromres.2010.10.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  13 in total

Review 1.  The intersection of protein disulfide isomerase and cancer associated thrombosis.

Authors:  Jack D Stopa; Jeffrey I Zwicker
Journal:  Thromb Res       Date:  2018-04       Impact factor: 3.944

2.  Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome.

Authors:  Valerio De Stefano
Journal:  Haematologica       Date:  2018-09       Impact factor: 9.941

3.  Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.

Authors:  Florian Moik; Wei-Shin Evelyn Chan; Sarah Wiedemann; Christoph Hoeller; Felix Tuchmann; Marie-Bernadette Aretin; Thorsten Fuereder; Sabine Zöchbauer-Müller; Matthias Preusser; Ingrid Pabinger; Cihan Ay
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

Review 4.  Update on Guidelines for the Management of Cancer-Associated Thrombosis.

Authors:  Michael B Streiff; Syed Ali Abutalib; Dominique Farge; Martina Murphy; Jean M Connors; Gregory Piazza
Journal:  Oncologist       Date:  2020-12-04

5.  Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.

Authors:  Florian Posch; Stefanie Hofer; Johannes Thaler; Lena Hell; Oliver Königsbrügge; Ella Grilz; Lisa-Marie Mauracher; Johanna Gebhart; Christine Marosi; Bernd Jilma; Ingrid Pabinger; Cihan Ay
Journal:  Transl Res       Date:  2019-08-29       Impact factor: 7.012

Review 6.  Cancer-associated pathways and biomarkers of venous thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Blood       Date:  2017-08-14       Impact factor: 22.113

7.  Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.

Authors:  Yohei Hisada; Kenison B Garratt; Anaum Maqsood; Steven P Grover; Tomohiro Kawano; Brian C Cooley; Jonathan Erlich; Florian Moik; Matthew J Flick; Ingrid Pabinger; Nigel Mackman; Cihan Ay
Journal:  Blood Adv       Date:  2021-01-26

Review 8.  Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.

Authors:  Hyungseop Kim; Woo-Baek Chung; Kyoung Im Cho; Bong-Joon Kim; Jeong-Sook Seo; Seong-Mi Park; Hak Jin Kim; Ju-Hee Lee; Eun Kyoung Kim; Ho-Joong Youn
Journal:  J Cardiovasc Ultrasound       Date:  2018-03-28

9.  Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.

Authors:  Ella Grilz; Oliver Königsbrügge; Florian Posch; Manuela Schmidinger; Robert Pirker; Irene M Lang; Ingrid Pabinger; Cihan Ay
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

10.  Risk Factors for Gastric Cancer-Associated Thrombotic Diseases in a Han Chinese Population.

Authors:  Bo Song; Yamei Wang; Xiuzhi Zhu; Li Zhang; Hui Zhou; Hongmei Zhang; Tianliang Zhang; Wansheng Ji
Journal:  Biomed Res Int       Date:  2021-05-21       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.